Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.
(tobramycin solution for inhalation)
*TOBI is a registered trademark
(Tobramycin Inhalation Powder)
* TOBI and Podhaler are registered trademarks
Protein-tyrosine Kinase Inhibitor
*Tasigna is a registered trademark
Anticonvulsant, Antimanic, For Symptomatic Relief Of Trigeminal Neuralgia
*Tegretol is a registered trademark
*Transderm-Nitro is a registered trademark
Anti-Motion Sickness Agent
*Transderm-V is a registered trademark
*Trileptal is a registered trademark
Novartis is one of the industry’s biggest investors in research.
This information is intended for Canadian healthcare professionals only
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
Sandoz is one of the leaders in the development, manufacturing and distribution of generic pharmaceutical products.